Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.86 USD | +1.76% |
|
+0.13% | -22.02% |
06-20 | Disc Medicine Insider Bought Shares Worth $3,000,024, According to a Recent SEC Filing | MT |
06-17 | BMO Capital Adjusts Price Target on Disc Medicine to $70 From $50, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.63% | 1.34B | |
+20.56% | 45.51B | |
-8.11% | 38.52B | |
+38.85% | 38.13B | |
+27.00% | 30.74B | |
-13.50% | 26.03B | |
+13.35% | 25.92B | |
+46.00% | 14.13B | |
+36.79% | 12.73B | |
-6.22% | 11.29B |
- Stock Market
- Equities
- IRON Stock
- News Disc Medicine, Inc.
- Leerink Partners Cuts Price Target on Disc Medicine to $65 From $77, Keeps Outperform Rating